S. 2529

119th CongressIn committee

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Sponsored by Jon Husted (Republican-OH)

Healthcare Costs & Access Healthcare & Public Health Pharmaceutical Policy

Cosponsors

1

Actions

2

Roll calls

0

Amendments

0

Related bills

1

Actions

Jul 30, 2025 · Library of Congress

Introduced in Senate

Jul 30, 2025 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest activity

Activity

July 2026

Lobbying reported · Haleon US Holdings · Jul 20

Haleon US Holdings reported 2nd Quarter (Apr 1 - June 30) lobbying for Haleon US Holdings — $260,000

BillsH.R. 1 H.R. 6868 H.R. 7366 S. 2529 S. 3677

Lobbying reported · Consumer Healthcare Products Association (CHPA) · Jul 14

Consumer Healthcare Products Association (CHPA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Consumer Healthcare Products Association (CHPA) — $199,750

BillsH.R. 1 H.R. 1219 H.R. 2821 H.R. 3686 H.R. 3722 H.R. 4273 H.R. 4958 H.R. 5027 H.R. 5371 H.R. 6868 H.R. 7291 H.R. 7366 H.R. 8370 H.R. 8385 H.R. 8933 S. 355 S. 2292 S. 2529 S. 3788 S. 4587

You’re all caught up.